Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor. [electronic resource] by
- Kreft, A
- Nelson, J
- Musser, J
- Failli, A
- Shah, U
- Kubrak, D
- Banker, A
- Steffan, R
- Schiehser, G
- Sturm, R
Producer: 19940131
In:
Agents and actions vol. 39 Spec No
Availability: No items available.
|
|
10.
|
|
|
11.
|
A putative sirolimus (rapamycin) effector protein. [electronic resource] by
- Chen, Y
- Chen, H
- Rhoad, A E
- Warner, L
- Caggiano, T J
- Failli, A
- Zhang, H
- Hsiao, C L
- Nakanishi, K
- Molnar-Kimber, K L
Producer: 19940929
In:
Biochemical and biophysical research communications vol. 203
Availability: No items available.
|
|
12.
|
Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugs. [electronic resource] by
- Kreft, A F
- Failli, A A
- Musser, J H
- Kubrak, D M
- Banker, A L
- Steffan, R
- Demerson, C A
- Nelson, J A
- Shah, U S
- Gray, W
Producer: 19920910
In:
Drugs under experimental and clinical research vol. 17
Availability: No items available.
|